Drawing for NEXPOWDER

USPTO serial 79283530

NEXPOWDER

Reviewed by CopyMark Law Group

Reg. 7361940Status 700Registered
Filing date
Status date
Registration date
Apr 23, 2024
Examiner
HARMON, RAYMOND E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEXPOWDER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KISUK LEE

KISUK LEE HARNESS, DICKEY & PIERCE, PLC7700 BONHOMME AVE, SUITE 400ST. LOUIS, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicines for the treatment of gastrointestinal ulcer for animals; anti-adhesion gels for use with wound drainage devices for gastrointestinal endoscopic use; pharmaceutical preparations for wounds; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of cancer; gelatin for medical purposes, namely, pharmaceutical gels for use in controlling bleeding for gastrointestinal endoscopic use; hemostatics for medical purposes for gastrointestinal endoscopic use; chemical preparations for medical purposes for gastrointestinal endoscopic use, namely, for treating gastrointestinal bleeding; pharmaceutical compositions in the nature of endoscopic hemostatic agents for gastrointestinal endoscopic use; pharmaceuticals for the treatment of gastrointestinal ulcer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumors; haemostatic preparations for medical purposes for gastrointestinal endoscopic use; anti-cancer preparations; vasoconstrictors; surgical cements in the nature of bone cement for surgical and orthopedic purposes; surgical glues; medical adhesives for binding woundsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 24, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2024TMBNTTAB RELEASE CASE TO TRADEMARKS—
Mar 15, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Dec 15, 2023OP.DOP.DS (DISMISSED IN PART/SUSTAINED IN PART)—
Oct 10, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 22, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 22, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 12, 2021RFNTREFUSAL PROCESSED BY IB—
Mar 15, 2021OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 12, 2021OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Mar 12, 2021OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Mar 11, 2021OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Mar 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 1, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 1, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 1, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 30, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 29, 2021ALIEASSIGNED TO LIE—
Oct 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 21, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 14, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 29, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 29, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2020DOCKASSIGNED TO EXAMINER—
Apr 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance